- Home
- NXGL vs DRIO Comparison
NXGL vs DRIO Comparison
Compare NXGL & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXGL
- DRIO
- Stock Information
- Founded
- NXGL 1997
- DRIO 2011
- Country
- NXGL United States
- DRIO United States
- Employees
- NXGL N/A
- DRIO N/A
- Industry
- NXGL Medical/Dental Instruments
- DRIO Medical/Dental Instruments
- Sector
- NXGL Health Care
- DRIO Health Care
- Exchange
- NXGL Nasdaq
- DRIO Nasdaq
- Market Cap
- NXGL 18.7M
- DRIO 21.9M
- IPO Year
- NXGL 2021
- DRIO N/A
- Fundamental
- Price
- NXGL $2.22
- DRIO $9.85
- Analyst Decision
- NXGL
- DRIO Strong Buy
- Analyst Count
- NXGL 0
- DRIO 2
- Target Price
- NXGL N/A
- DRIO $50.00
- AVG Volume (30 Days)
- NXGL 50.3K
- DRIO 28.6K
- Earning Date
- NXGL 08-12-2025
- DRIO 11-06-2025
- Dividend Yield
- NXGL N/A
- DRIO N/A
- EPS Growth
- NXGL N/A
- DRIO N/A
- EPS
- NXGL N/A
- DRIO N/A
- Revenue
- NXGL $11,672,000.00
- DRIO $27,148,000.00
- Revenue This Year
- NXGL $46.60
- DRIO $0.74
- Revenue Next Year
- NXGL $47.96
- DRIO $19.61
- P/E Ratio
- NXGL N/A
- DRIO N/A
- Revenue Growth
- NXGL 133.02
- DRIO 41.79
- 52 Week Low
- NXGL $2.10
- DRIO $7.60
- 52 Week High
- NXGL $5.10
- DRIO $31.00
- Technical
- Relative Strength Index (RSI)
- NXGL 41.78
- DRIO 45.82
- Support Level
- NXGL $2.18
- DRIO $8.91
- Resistance Level
- NXGL $2.59
- DRIO $10.60
- Average True Range (ATR)
- NXGL 0.15
- DRIO 1.13
- MACD
- NXGL -0.01
- DRIO 0.14
- Stochastic Oscillator
- NXGL 9.76
- DRIO 45.31
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.